Unknown

Dataset Information

0

LEF-1 drives aberrant ?-catenin nuclear localization in myeloid leukemia cells.


ABSTRACT: Canonical Wnt/?-catenin signaling is frequently dysregulated in myeloid leukemias and is implicated in leukemogenesis. Nuclear-localized ?-catenin is indicative of active Wnt signaling and is frequently observed in acute myeloid leukemia (AML) patients; however, some patients exhibit little or no nuclear ?-catenin even where cytosolic ?-catenin is abundant. Control of the subcellular localization of ?-catenin therefore represents an additional mechanism regulating Wnt signaling in hematopoietic cells. To investigate the factors mediating the nuclear-localization of ?-catenin, we carried out the first nuclear/cytoplasmic proteomic analysis of the ?-catenin interactome in myeloid leukemia cells and identified putative novel ?-catenin interactors. Comparison of interacting factors between Wnt-responsive cells (high nuclear ?-catenin) versus Wnt-unresponsive cells (low nuclear ?-catenin) suggested the transcriptional partner, LEF-1, could direct the nuclear-localization of ?-catenin. The relative levels of nuclear LEF-1 and ?-catenin were tightly correlated in both cell lines and in primary AML blasts. Furthermore, LEF-1 knockdown perturbed ?-catenin nuclear-localization and transcriptional activation in Wnt-responsive cells. Conversely, LEF-1 overexpression was able to promote both nuclear-localization and ?-catenin-dependent transcriptional responses in previously Wnt-unresponsive cells. This is the first ?-catenin interactome study in hematopoietic cells and reveals LEF-1 as a mediator of nuclear ?- catenin level in human myeloid leukemia.

SUBMITTER: Morgan RG 

PROVIDER: S-EPMC6601079 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications


Canonical Wnt/β-catenin signaling is frequently dysregulated in myeloid leukemias and is implicated in leukemogenesis. Nuclear-localized β-catenin is indicative of active Wnt signaling and is frequently observed in acute myeloid leukemia (AML) patients; however, some patients exhibit little or no nuclear β-catenin even where cytosolic β-catenin is abundant. Control of the subcellular localization of β-catenin therefore represents an additional mechanism regulating Wnt signaling in hematopoietic  ...[more]

Similar Datasets

| S-EPMC3613703 | biostudies-literature
| S-EPMC4627329 | biostudies-literature
| S-EPMC4297867 | biostudies-literature
2024-05-09 | PXD052126 |
| S-EPMC3336969 | biostudies-literature
| S-EPMC2847740 | biostudies-literature
| S-EPMC4824155 | biostudies-literature
| S-EPMC2390926 | biostudies-literature
| S-EPMC551520 | biostudies-literature
| S-EPMC4491612 | biostudies-literature